These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11877365)

  • 81. [Pharmacological analysis of the role of central alpha-2 adrenergic and imidazoline receptors in mechanism of the hypotensive effect of clonidine in rats].
    Kuz'min AI; Lodygin DN; Kalenikova EI; Bychkova EIu; Khokhlova ON; Murashev AN; Medvedev OS
    Eksp Klin Farmakol; 2000; 63(4):24-8. PubMed ID: 11022301
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Actions of L-NAME and methylene blue on the hypotensive effects of clonidine and rilmenidine in the anesthetized rat.
    Soares de Moura RS; Leão MC; Castro Resende AC; Moreira CF; Sena KM; Silveira SS; Lima AF; Nunes FR; Mesquita Ferreira AG
    J Cardiovasc Pharmacol; 2000 May; 35(5):791-5. PubMed ID: 10813383
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Comparative study of NMDA and AMPA/kainate receptors involved in cardiovascular inhibition produced by imidazoline-like drugs in anaesthetized rats.
    Wang LG; Zeng J; Yuan WJ; Su DF; Wang WZ
    Exp Physiol; 2007 Sep; 92(5):849-58. PubMed ID: 17573415
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [[Central agents in arterial hypertension: back to the future].
    Robles NR
    Nefrologia; 2000; 20(4):302-10. PubMed ID: 11039256
    [No Abstract]   [Full Text] [Related]  

  • 85. Chronic ethanol attenuates centrally-mediated hypotension elicited via alpha(2)-adrenergic, but not I(1)-imidazoline, receptor activation in female rats.
    El-Mas MM; Abdel-Rahman AA
    Life Sci; 2009 Jan; 84(3-4):111-8. PubMed ID: 19041658
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Heterozygous alpha 2A-adrenergic receptor mice unveil unique therapeutic benefits of partial agonists.
    Tan CM; Wilson MH; MacMillan LB; Kobilka BK; Limbird LE
    Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12471-6. PubMed ID: 12205290
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Imidazoline receptors: a challenge.
    Bousquet P; Bruban V; Schann S; Feldman J
    Pharm Acta Helv; 2000 Mar; 74(2-3):205-9. PubMed ID: 10812959
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Rilmenidine: a novel antihypertensive agent.
    Safar ME
    Am J Med; 1989 Sep; 87(3C):24S-29S. PubMed ID: 2571292
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Pretreatment with the dopamine agonist quinpirole inhibits central antihypertensive mechanisms in rats.
    van den Buuse M; Tritton SB
    Clin Exp Pharmacol Physiol; 1997; 24(9-10):661-6. PubMed ID: 9315366
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Rilmenidine elevates cytosolic free calcium concentration in suspended cerebral astrocytes.
    Ozog MA; Wilson JX; Dixon SJ; Cechetto DF
    J Neurochem; 1998 Oct; 71(4):1429-35. PubMed ID: 9751174
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Rilmenidine (S 3341) and the sympathoadrenal system: adrenoreceptors, plasma and adrenal catecholamines in dogs.
    Valet P; Tran MA; Damase-Michel C; de Saint-Blanquat G; Dang Tran L; Anglade F; Koenig-Berard E; Montastruc JL
    J Auton Pharmacol; 1988 Dec; 8(4):319-26. PubMed ID: 2908112
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Modulation of sympathetic outflow by centrally acting antihypertensive drugs.
    van Zwieten PA
    Cardiovasc Drugs Ther; 1996 Jun; 10 Suppl 1():283-9. PubMed ID: 8827951
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Preliminary clinical pharmacological studies of S3341, a new hypotensive agent, and comparison with clonidine in normal males.
    Weerasuriya K; Shaw E; Turner P
    Eur J Clin Pharmacol; 1984; 27(3):281-6. PubMed ID: 6150856
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Mechanism of hypotensive action of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST-155) in the cat.
    Magus RD; Long JP
    J Pharm Sci; 1968 Apr; 57(4):594-8. PubMed ID: 5652149
    [No Abstract]   [Full Text] [Related]  

  • 95. Alpha 2-adrenergic mechanisms of analgesia: strategies for improving their therapeutic window and identification of the novel, potent alpha 2A-adrenergic receptor agonist, S 18616.
    Millan MJ
    Adv Pharmacol; 1998; 42():575-9. PubMed ID: 9327967
    [No Abstract]   [Full Text] [Related]  

  • 96. Cardiovascular effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 155). II. Central sympathetic structures.
    Schmitt H; Boissier JR; Giudicelli JF; Fichelle J
    Eur J Pharmacol; 1968 Mar; 2(5):340-6. PubMed ID: 5654157
    [No Abstract]   [Full Text] [Related]  

  • 97. Chronically lowering sympathetic activity protects sympathetic nerves in spleens from aging F344 rats.
    Perez SD; Kozic B; Molinaro CA; Thyagarajan S; Ghamsary M; Lubahn CL; Lorton D; Bellinger DL
    J Neuroimmunol; 2012 Jun; 247(1-2):38-51. PubMed ID: 22546498
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Structure activity relationships for central and peripheral alpha adrenergic activities of imidazoline derivatives.
    Boudier HS; de Boer J; Smeets G; Lien EJ; van Rossum J
    Life Sci; 1975 Aug; 17(3):377-85. PubMed ID: 240098
    [No Abstract]   [Full Text] [Related]  

  • 99. Central alpha 2-adrenoceptors and blood pressure regulation in the rat.
    Nunes JP
    Eur J Pharmacol; 1995 May; 278(2):183-5. PubMed ID: 7672004
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Sympathoinhibitory function of the alpha(2A)-adrenergic receptor subtype.
    Makaritsis KP; Johns C; Gavras I; Altman JD; Handy DE; Bresnahan MR; Gavras H
    Hypertension; 1999 Sep; 34(3):403-7. PubMed ID: 10489385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.